ANGIONI, MARIA MADDALENA
 Distribuzione geografica
Continente #
EU - Europa 62.164
NA - Nord America 2.533
AS - Asia 1.360
SA - Sud America 169
AF - Africa 41
OC - Oceania 14
Totale 66.281
Nazione #
IT - Italia 61.287
US - Stati Uniti d'America 2.464
SG - Singapore 482
CN - Cina 404
DE - Germania 299
SE - Svezia 156
BR - Brasile 134
VN - Vietnam 134
FI - Finlandia 94
UA - Ucraina 76
HK - Hong Kong 70
GB - Regno Unito 69
FR - Francia 50
BD - Bangladesh 47
CA - Canada 47
IN - India 39
JP - Giappone 35
RU - Federazione Russa 29
ES - Italia 22
KR - Corea 22
TR - Turchia 20
NL - Olanda 18
IQ - Iraq 16
ZA - Sudafrica 15
AU - Australia 14
PL - Polonia 14
LT - Lituania 10
PK - Pakistan 10
BE - Belgio 9
IR - Iran 9
EG - Egitto 8
ID - Indonesia 8
UZ - Uzbekistan 8
AR - Argentina 7
CL - Cile 7
MA - Marocco 7
MY - Malesia 7
PH - Filippine 7
AT - Austria 6
CO - Colombia 6
MX - Messico 6
TW - Taiwan 6
AZ - Azerbaigian 5
EC - Ecuador 5
SA - Arabia Saudita 5
DZ - Algeria 4
GR - Grecia 4
JO - Giordania 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
IE - Irlanda 3
IL - Israele 3
JM - Giamaica 3
KG - Kirghizistan 3
KH - Cambogia 3
TT - Trinidad e Tobago 3
AL - Albania 2
BH - Bahrain 2
BO - Bolivia 2
CH - Svizzera 2
DK - Danimarca 2
ET - Etiopia 2
HN - Honduras 2
KE - Kenya 2
LV - Lettonia 2
NP - Nepal 2
PA - Panama 2
PE - Perù 2
PS - Palestinian Territory 2
RO - Romania 2
SV - El Salvador 2
BG - Bulgaria 1
BY - Bielorussia 1
EE - Estonia 1
GE - Georgia 1
KZ - Kazakistan 1
ML - Mali 1
MR - Mauritania 1
MV - Maldive 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PT - Portogallo 1
TN - Tunisia 1
UY - Uruguay 1
VE - Venezuela 1
Totale 66.281
Città #
Cagliari 59.839
Uta 1.239
Singapore 285
Dallas 274
Ashburn 252
San Jose 167
Chandler 146
Boardman 117
Houston 105
Fairfield 102
Nyköping 86
Beijing 80
Los Angeles 78
Woodbridge 76
Helsinki 73
Ann Arbor 67
Hong Kong 60
Wilmington 56
Dearborn 53
New York 52
Cambridge 51
Council Bluffs 51
Seattle 50
The Dalles 44
Shanghai 42
Jacksonville 40
Santa Clara 39
Ho Chi Minh City 38
Lauterbourg 33
Munich 33
Chicago 29
Dong Ket 28
Boston 24
Rome 24
Hefei 23
Buffalo 22
Hanoi 20
Milan 19
Tokyo 19
Seoul 17
Nanjing 15
Brooklyn 13
Frankfurt am Main 13
Nuremberg 12
Atlanta 11
Denver 11
Madrid 11
Orem 11
São Paulo 11
Warsaw 11
Amsterdam 10
London 10
Redondo Beach 10
San Diego 10
Toronto 10
Brussels 9
Changsha 9
Manchester 9
Montreal 9
Mumbai 9
Rio de Janeiro 9
Shenzhen 9
Vancouver 9
Baghdad 8
Brisbane 8
Chennai 8
Düsseldorf 8
Elk Grove Village 8
Guangzhou 8
Phoenix 8
Stockholm 8
Da Nang 7
Redwood City 7
Tashkent 7
Zola Predosa 7
Johannesburg 6
Leawood 6
Salt Lake City 6
Turku 6
Zhengzhou 6
City of London 5
Dhaka 5
Jinan 5
Kocaeli 5
Miami 5
Nanchang 5
Ningbo 5
Norwalk 5
Paris 5
San Mateo 5
Selargius 5
Sestu 5
Tianjin 5
Ankara 4
Baku 4
Bexley 4
Cairo 4
Casablanca 4
Charlotte 4
Falls Church 4
Totale 64.309
Nome #
FRI0357 DRUG-INDUCED REMISSION AND SUBCLINICAL ACTIVITY IN PSORIATIC ARTHRITIS: TRANSCRIPTIONAL PROFILING TO CHARACTERIZE THE DISEASE STATE 10.751
YAP activation is an early event and a potential therapeutic target in liver cancer development 4.055
Nrf2, but not β-catenin, mutation represents an early event in rat hepatocarcinogenesis 3.663
Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis 3.192
Assessment Of Circulating Endothelial Cells And Their Progenitors As Potential Biomarkers Of Disease Activity And Damage Accrual In Behçet's Syndrome 3.182
Gene expression profiling of monozygotic twins affected by psoriatic arthritis 3.069
Expression analysis of HLA-E and NKG2A and NKG2C receptors points at a role for natural killer function in ankylosing spondylitis 3.066
The metabolic gene HAO2 is downregulated in hepatocellular carcinoma and predicts metastasis and poor survival 2.914
AIF-1 gene does not confer susceptibility to Behçet's disease: Analysis of extended haplotypes in Sardinian population 2.828
NRF2 mutations are frequent in early rat preneoplastic hepatic lesions and in human hepatocellular carcinomas positive for the stem/progenitor cell marker KRT-19 2.791
A long term, non-tumorigenic rat hepatocyte cell line and its malignant counterpart, as tools to study hepatocarcinogenesis 2.743
Molecular modifications induced by mud-bath therapy in patients with osteoarthritis 2.262
Spa therapy induces clinical improvement and protein changes in patients with chronic back pain 2.260
Neonatal exposure to estradiol in rats influences neuroactive steroid concentrations, GABA(A) receptor expression, and behavioral sensitivity to anxiolytic drugs 2.048
La somministrazione neonatale di estrogeno modifica i livelli di steroidi neuroattivi, la plasticità dei recettori GABAA e la sensibilitò ai farmaci ansiolitici nelle femmine adulte 1.870
Changes in neuroactive steroids levels, GABAA receptor plasticity and sensitivity to anxiolytic drugs induced by neonatal exposure to estrogen 1.818
Current smoking predicts inadequate response to methotrexate monotherapy in rheumatoid arthritis patients naïve to DMARDs: Results from a retrospective cohort study 1.655
Changes in neuroactive steroid levels, GABAA receptor plasticity and sensitivity to anxiolytic drugs induced by neonatal exposure to estrogen 1.612
Targeted Therapies in Axial Psoriatic Arthritis 1.177
Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis 1.159
Molecular profiling of clinical remission in psoriatic arthritis reveals dysregulation of FOS and CCDC50 genes: a gene expression study 1.071
Brain-reactive autoantibodies in neuropsychiatric systemic lupus erythematosus 1.057
Effect of anti-P ribosomal and anti-NR2 antibodies on depression and cognitive processes in SLE: an integrated clinical and functional MRI study 1.053
Imbalanced MMP-3 and MMP-12 serum levels in systemic lupus erythematosus patients with Jaccoud's arthropathy and a distinctive MRI pattern 1.001
Response to treatment with chemical and biological inhibitors of c-met mutated form 904
The Challenging Differentiation of Psoriatic Arthritis from Other Arthropathies and Nonspecific Arthralgias in Patients with Psoriasis: Results of a Cross-Sectional Rheumatologic Assessment of a Large Dermatologic Cohort 779
SAT0035 IS PHARMACOLOGICAL CLINICAL REMISSION SYNONYMOUS WITH BIOLOGICAL INACTIVE DISEASE? DIFFERENTIAL GENE EXPRESSION ANALYSIS IN RHEUMATOID ARTHRITISAND HEALTY CONTROLS 722
Treatment of psoriasis with different classes of biologics reduces the likelihood of peripheral and axial psoriatic arthritis development 553
GRAPPA 2020 Research Award Recipients 502
Psychometric Properties of Patient Global Assessment in Psoriatic Arthritis: A Systematic Literature Review 246
Stratifying patients by TNFSF13B genotype revealed increased flare and renal flare risk, but a greater benefit from belimumab: a potential biomarker for personalized treatment in systemic lupus erythematosus 177
The role of Anti-PAD4, Anti-CarP, and Anti-RA33 antibodies combined with RF and ACPA in predicting abatacept response in rheumatoid arthritis 93
The metabolomic profile of psoriatic arthritis patients unveils the unbalance of disease-related molecules and pathways 68
Ultrasound-Guided Synovial Biopsy Can Be Effectively and Safely Performed in Different Clinical Settings Favouring a Widespread Application of Precision Medicine in Rheumatoid Arthritis: A Post-hoc Analysis of Three Clinical Trials 54
The role of a multidisciplinary approach in the early and differential diagnosis of inflammatory bowel disease–related spondyloarthritis: insights from a cross-sectional study 22
Totale 66.417
Categoria #
all - tutte 80.917
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.917


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021308 0 0 0 0 0 0 0 0 0 0 0 308
2021/20223.399 373 198 113 183 281 223 180 203 333 408 465 439
2022/20235.102 506 797 702 459 451 509 244 282 289 325 346 192
2023/20246.650 241 163 216 444 797 764 754 1.457 276 303 662 573
2024/202520.071 8.075 4.996 3.771 1.023 503 578 638 50 88 90 146 113
2025/20263.315 189 192 360 248 259 190 647 269 243 285 344 89
Totale 66.417